Buy or sell EarLens stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

EarLens Stock

EarLens is a medical device company specialized in manufacturing hearing aids



Notable Investors


Menlo Park CA, US

Total Funding


About EarLens Stock

EarLens Corporation is a privately held medical device company committed to providing hearing impaired patients a hearing solution that is designed to change the current standard of care for sound performance. The EarLens System's unique mechanism of direct sound delivery potentially opens the door to a level of sound performance achieved by no hearing aid on the market today. Unlike traditional hearing aids, which are in effect tiny speakers that simply turn up the volume on air conducted sound, the EarLens Contact Hearing Device™ is the world’s first to use light to transmit sound.

Funding History

May 2010$4.6M
July 2011$500K
January 2013$1.6M
April 2014$40.0M
June 2016$34.0M
June 2017$73.0M
June 2017$45.0M
October 2018$87.0M



Brent Edwards

Founder and Chief Medical Officer

Dr. Rodney Perkins


William Facteau

Other Companies

Addiction Campuses of America

Addiction Campuses of America owns, operates and manages behavioral healthcare campuses across the United States.


CredSimple is an NCQA certified credentialing and provider data management solution.

Synthetic Genomics

Synthetic Genomics develops genomic-driven solutions to address global energy and environmental challenges.


Tempus is a technology company that has built an operating system to battle cancer.

EquityZen does not have an affiliation with, formal relationship with, or endorsement from EarLens or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 70K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: